The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study

References

• Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: Results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 2009;74:1–8.
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008;26:3770–6.
   PubMed Web of Science ®Google Scholar
• Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007;85:74–82.
   PubMed Web of Science ®Google Scholar
• Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, . Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425–39.
   PubMed Web of Science ®Google Scholar
• Caudell JJ, Burnett OL III, Schaner PE, Bonner JA, Duan J. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer. Int J Radiat Oncol Biol Phys 2010;77:462–7.
   PubMed Web of Science ®Google Scholar
• Webster GJ, Rowbottom CG, Ho KF, Slevin NJ, Mackay RI. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck. Int J Radiat Oncol Biol Phys 2008;72:617–22.
   PubMed Web of Science ®Google Scholar
• Christianen MEMC, Schilstra C, Beetz I, Muijs CT, Chouvalova O, Burlage FR, . Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study. Radiother Oncol 2011 (in press) doi: 10.1016/j.radonc.2011.08.009.
   Google Scholar
• Fua TF, Corry J, Milner AD, Cramb J, Walsham SF, Peters LJ. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: Clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys 2007;67:976–81.
   PubMed Web of Science ®Google Scholar
• van der Laan HP, Christianen MEMC, Bijl HP, Schilstra C, Langendijk JA. The potential benefit of swallowing sparing intensity-modulated radiotherapy to reduce swallowing dysfunction: An in silico planning comparative study. 2012;103: 76–81.
   Google Scholar
• van de Water TA, Bijl HP, Schilstra C, Pijls-Johannesma M, Langendijk JA. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: A systematic review of literature. Oncologist 2011;16:366–77.
   PubMed Web of Science ®Google Scholar
• Ask A, Bjork-Eriksson T, Zackrisson B, Blomquist E, Glimelius B. The potential of proton beam radiation therapy in head and neck cancer. Acta Oncol 2005;44:876–80.
   PubMed Web of Science ®Google Scholar
• Mendenhall NP, Malyapa RS, Su Z, Yeung D, Mendenhall WM, Li Z. Proton therapy for head and neck cancer: Rationale, potential indications, practical considerations, and current clinical evidence. Acta Oncol 2011;50:763–71.
   PubMed Web of Science ®Google Scholar
• Schippers JM, Lomax AJ. Emerging technologies in proton therapy. Acta Oncol 2011;50:838–50.
   PubMed Web of Science ®Google Scholar
• van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2012;82:e313–9.
   PubMedGoogle Scholar
• van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug EB, . Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011;79:1216–24.
   PubMed Web of Science ®Google Scholar
• Gregoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 2006;79: 15–20.
   PubMed Web of Science ®Google Scholar
• Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, . CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. Radiother Oncol 2003;69:227–36.
   PubMed Web of Science ®Google Scholar
• van de Water TA, Bijl HP, Westerlaan HE, Langendijk JA. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol 2009;93:545–52.
   PubMed Web of Science ®Google Scholar
• Christianen MEMC, Langendijk JA, Westerlaan HE, van de Water TA, Bijl HP. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol 2011;101:394–402.
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341–6.
   PubMed Web of Science ®Google Scholar
• Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, . Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999;17:1008–19.
   PubMed Web of Science ®Google Scholar
• Schwartz DL, Hutcheson K, Barringer D, Tucker SL, Kies M, Holsinger FC, . Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:1356–65.
   PubMed Web of Science ®Google Scholar
• Eisbruch A, Kim HM, Feng FY, Lyden TH, Haxer MJ, Feng M, . Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: Swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys 2011;81:e93–9.
   PubMed Web of Science ®Google Scholar
• Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: The potential effects of calculational uncertainties. Phys Med Biol 2008;53: 1027–42.
   PubMed Web of Science ®Google Scholar
• Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008;53: 1043–56.
   PubMed Web of Science ®Google Scholar
• Park PC, Zhu XR, Lee AK, Sahoo N, Melancon AD, Zhang L, . A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties. Int J Radiat Oncol Biol Phys 2012;82: e329–36.
   PubMedGoogle Scholar
• Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol 2006;80:263–7.
   PubMed Web of Science ®Google Scholar